Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy
Erting Tang, Yifei Hu, Guoshuai Cao…·Jun Huang
This study shows that low-strength type I interferon signaling enhances CAR T-cell efficacy against B-cell lymphoma and leukemia without causing in vivo toxicity.